Fully Integrated Automatic On-site Quick DNA Test System Quick TargSeq B
The Fully Integrated Automatic On-site Quick DNA Test System Quick TargSeq B, a jointly developed forensic platform with independent intellectual property rights by the Institute of Forensic Science of China, Tsinghua University, CapitalBio Group, and CapitalBio Technology, adopts modular microfluidic chip technology to integrate the entire testing process from sample preprocessing to result output, enabling fully automated on-site DNA testing in 2 hours in extreme environments such as high altitudes (0-5000m) and vehicle-mounted conditions, supporting multiple sample types and reagent functions for various forensic and public security application scenarios.
Microfluidic Platform
CapitalBiotech developed the platform for multi-target nucleic acid rapid detection.
Solutions for Maternal and Child Healthcare
Based on the powerful testing platform and independent research and development capabilities, CapitalBiotech formed a congenital disability prevention and control program.
Microbiome Sequencing Service
Microorganism exists in the human body, plant, soil, sea, and other environments. The collection of all microorganism species and their genetic information and function is named as the microbiome. At ...
CapitalBiotech COVID-19 Mobile Laboratory
Integrated with global leading chip laboratory technology and swab robot sampling technology, COVID-19 Mobile Laboratory enables "sample in, result out" detection that is borh suscepible and rapid in various demand scenarios, such as border ports, CDC, grassroots hospitals, etc.